Article
A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection.
International journal of molecular sciences - 9 Mar 2016
Kishida Yutaka, Imaizumi Naohiko, Tanimura Hirohisa, Kashiwamura Shinichiro, Kashiwagi Toru
Abstract excerpt
The restoration of innate immune responses has potential as a novel therapeutic strategy for chronic hepatitis C (CHC). We compared the efficacy and safety of induction therapy (IT) with natural interferon-β (n-IFN-β) followed by pegylated-IFN-α/ribavirin (PR) alone (group A, n = 30) and IT with a protease inhibitor (PI) (simeprevir or vaniprevir)/PR (group B, n = 13) in CHC patients with genotype 1b and high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.